HLA-A*2402 Restricted Peptide Vaccine Therapy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HLA-A*2402 Restricted Peptide Vaccine Therapy, covering 2009-11-19 to 2012-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer [Phase 1]